Human adenovirus 36 (ATCC® VR-1610)

Classification: Adenoviridae, Mastadenovirus, Human adenovirus D  /  Product Format: frozen

Permits and Restrictions

View Permits

Classification Adenoviridae, Mastadenovirus, Human adenovirus D
Agent Human adenovirus 36
Strain 275
Applications
Respiratory research
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format frozen
Storage Conditions -70°C or colder
Comments
Prepared from ATCC® VR-913™ following treatment to remove mycoplasma contamination.
No serological cross-reaction with other human adenoviruses. Hemagglutinin active for rat and human erythrocytes.
Effect on Host
CPE, typical adenovirus rounding beginning in clusters
Recommended Host
A549 (ATCC® CCL-185™)
Growth Conditions Recommendations for Infection: For best results, plate cells 24-48 hours in advance. Infect at about 80% confluence using a multiplicity of infection (MOI) of 0.1 to 1.0. Incubate at 37°C for 3-7 days, until CPE are well advanced in 100% of the culture. A 5% CO2 in air atmosphere is recommended.
Effect on Host
CPE, typical adenovirus rounding beginning in clusters
Name of Depositor R. Wigand, ATCC
Source Feces from human diabetic; derived from ATCC® VR-913™ following treatment to remove mycoplasma contamination.
References

Wigand R, et al. New human adenovirus (candidate adenovirus 36), a novel member of subgroup D. Arch. Virol. 64: 225-233, 1980. PubMed: 7406681

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation